ArticleIndian journal of palliative care
Management of Malignant Wound Myiasis with Ivermectin, Albendazole, and Clindamycin (Triple Therapy) in Advanced Head-and-Neck Cancer Patients: A Prospective Observational Study.
Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 31 citations in OpenAlex.
- [Case report of human myiasis caused by Cochliomyia hominivorax in Mexico].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Management of myiasis in advanced head and neck cancers: a comprehensive review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Review
- Unusually Extensive Furuncular Myiasis in a Returning Traveller from Rural Ethiopia Complicated by Streptococcus Pyogenes Secondary Infection Following Albendazole Therapy.Reports (MDPI) · 2026Article
- Palliative Management of Advanced Breast Carcinoma Complicated by Myiasis: First Case Report From Bangladesh.Clinical medicine insights. Case reports · 2026Article
- Article
- Successful conservative management of myiasis of an episiotomy wound and the uterine cavity postnatally: A case report.Case reports in women's health · 2025Article
- Myiasis infestation in advanced lip squamous cell carcinoma due to COVID-19 pandemic-related treatment delays.Revista do Instituto de Medicina Tropical de Sao Paulo · 2025Article
- Malignant fungating wounds assessment in palliative care: a scoping review.Frontiers in public health · 2025Article
- Challenge to Eliminate Parasite Palatal Infestation in a Deaf-Mute Geriatric Patient.Case reports in dentistry · 2025Article
- Grub in the mouth: an unusual case with review of literature.BMJ case reports · 2020Article
- Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.The EPMA journal · 2020Article
- Treatment of facial myiasis in an elderly patient with oral squamous cell carcinoma: Case report.International journal of surgery case reports · 2020Article
- Myiasis in patients with oral squamous cell carcinoma-a systematic review and protocol for management.Oral and maxillofacial surgery · 2019Article
- Maggots in the Intercostal Drain: Case Report of a Rare Presentation with a Brief Review of Literature.Indian journal of palliative careArticle
- Postpartum genital myiasis -Tropical parasitologyArticle
- Skin Myasis Associated with High-Risk Epidermoid Carcinoma in a Possible Lung Metastasis Patient.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMyiasis, tissue infestation by housefly larvae, is commonly found in malignant fungating wounds of cancer patients from climatic condition and lower socio-economic strata. AIM OF STUDY: It was aimed to study the effectiveness of systemic Ivermectin, Albendazole& Clindamycin (Triple Therapy) in reducing signs & symptoms associated with maggots in malignant head and neck wounds.
method25 adult, advanced head and neck cancer patients presenting with maggots either from wound, oral cavity or nostril, with ECOG score 3 or less were enrolled in this study. Symptoms were assessed using Edmonton Symptom Assessment Scale (ESAS) and wound by Wound Assessment Tool - Hospice, at baseline and then Days 1, 3, 5, and 7. All patients received 3 days course of oral Ivermectin 12 mg per day, Albendazole 400 mg twice per day and Clindamycin 300 mg three times per day for 5 days along with Terpentine oil dressing. All patients received oral Morphine as per their pain score.
resultsMean age (yrs) and weight (Kg) were 42.15 ± 8.23 and 52.31 ± 5.18 respectively. 84% patients were male. Mean oral morphine dose was 100.38 mg. There was significant decrease in number of maggots from day 0 (77.28 ± 13.465) to day 1 (20.60 ± 7.263; 73.34% reduction) to day 3 (1.52 ± 2.104; 92.62% reduction). We found statistically significant improvement (
conclusionSystemic treatment with Ivermectin, Albendazole and Clindamycin (Triple Therapy) enhances the removal of maggots, early recovery and relief from distress and associated symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.